1. Home
  2. XELB vs CARA Comparison

XELB vs CARA Comparison

Compare XELB & CARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XELB
  • CARA
  • Stock Information
  • Founded
  • XELB 2011
  • CARA 2004
  • Country
  • XELB United States
  • CARA United States
  • Employees
  • XELB N/A
  • CARA N/A
  • Industry
  • XELB Multi-Sector Companies
  • CARA Biotechnology: Pharmaceutical Preparations
  • Sector
  • XELB Miscellaneous
  • CARA Health Care
  • Exchange
  • XELB Nasdaq
  • CARA Nasdaq
  • Market Cap
  • XELB 19.0M
  • CARA 16.7M
  • IPO Year
  • XELB N/A
  • CARA 2014
  • Fundamental
  • Price
  • XELB $0.51
  • CARA $5.22
  • Analyst Decision
  • XELB
  • CARA Hold
  • Analyst Count
  • XELB 0
  • CARA 3
  • Target Price
  • XELB N/A
  • CARA $1.00
  • AVG Volume (30 Days)
  • XELB 359.0K
  • CARA 321.9K
  • Earning Date
  • XELB 12-20-2024
  • CARA 11-14-2024
  • Dividend Yield
  • XELB N/A
  • CARA N/A
  • EPS Growth
  • XELB N/A
  • CARA N/A
  • EPS
  • XELB N/A
  • CARA N/A
  • Revenue
  • XELB $9,337,000.00
  • CARA $8,686,000.00
  • Revenue This Year
  • XELB N/A
  • CARA N/A
  • Revenue Next Year
  • XELB $82.99
  • CARA N/A
  • P/E Ratio
  • XELB N/A
  • CARA N/A
  • Revenue Growth
  • XELB N/A
  • CARA N/A
  • 52 Week Low
  • XELB $0.33
  • CARA $2.71
  • 52 Week High
  • XELB $1.70
  • CARA $13.80
  • Technical
  • Relative Strength Index (RSI)
  • XELB 43.26
  • CARA 58.86
  • Support Level
  • XELB $0.33
  • CARA $3.96
  • Resistance Level
  • XELB $0.53
  • CARA $6.36
  • Average True Range (ATR)
  • XELB 0.09
  • CARA 1.00
  • MACD
  • XELB 0.01
  • CARA 0.13
  • Stochastic Oscillator
  • XELB 43.27
  • CARA 68.75

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain design, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About CARA Cara Therapeutics Inc.

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Share on Social Networks: